相关实验视频
Updated: May 5, 2026

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.3K
在患有甲状腺眼病的患者中给出了teprotumumab后的耳部症状
Madison V Epperson1, Sara Hughes2, Carla V Valenzuela1
1Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor.
概括
治疗甲状腺眼病的teprotumumab治疗通常会导致持续的听力损失,耳和头. 许多患者报告了对生活质量的重大影响,有些人后悔服用药物.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
背景情况:
- 德鲁马布是一种针对甲状腺眼病 (TED) 的新型生物治疗方法.
- 耳病的不良事件越来越多地被报告,但没有全面的特征.
- 了解这些事件对于患者管理和知情同意至关重要.
研究的目的:
- 在teprotumumab给药后,对主观的耳学不良事件进行表征.
- 评估这些事件对患者生活质量和药物感知的影响.
主要方法:
- 在第三级推中心的回顾案例系列.
- 包括32名成年TED患者接受了teprotumumab (2020-2023) 的治疗.
- 评估听力损失,耳,头和尤斯塔希管功能障碍,使用标准化的患者报告结果指标.
主要成果:
- 50%的患者报告在teprotumumab治疗期间听力损失,通常是渐进的,双边的和持久的.
- 在那些有听力损失的人中,37.5%的人感到头,87.5%的人听到耳声,87.5%的人报告生活质量下降.
- 欧斯塔基管功能障碍和的欧斯塔基管症状也被报告为轻度残疾.
结论:
- 托普慕马布的使用经常与主观听力损失,耳和头有关.
- 这些耳部病变可能是持续的,并显著影响患者的生活质量.
- 需要对这些不良事件的机制和管理进行进一步的调查.
相关概念视频
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32
Hypothyroidism II: Pathophysiology
26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26

